Excellent information. This podcast is a discussion between M.D. Peter Attia and Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
Link:
https://peterattiamd.com/michaelosterholm/Show notes if you want to skip around:
Discussed:
Recapping the brief history of COVID-19 and what potentially lies ahead [2:15];
Some positive news about immunity and reinfection [10:45];
Case fatality rateāthe challenge in finding the true rate, difference by country, and the impact of age, underlying conditions, and obesity [13:00];
What has to be true for less than 100,000 Americans to die from COVID-19? [24:30];
How do we best protect healthcare workers? [29:45];
Concerns about testing capabilityāreagent shortfall and a supply chain problem [39:30];
Vaccines and antiviralsāThe outlook, timing, and challenges [47:45];
Long term health of survivors of COVID-19 [56:45];
The impact of comorbiditiesāDiabetes, obesity, and immunosuppressed patients [59:30];
Understanding R0 and how the disease spreads [1:01:30];
The challenge of forecasting with so many unknowns [1:08:00];
What explains the difference in cases and fatalities in different parts of the world? [1:14:30];
Repurposed drugs/antivirals being considered for treatment optionsāany optimism? [1:16:45];
A parting message from Michael about what lies ahead [1:18:30]; and